Skinvisible (SKVI) Non-Current Debt (2011 - 2026)
Skinvisible's (SKVI) quarterly Non-Current Debt came in at $5.4 million in Q2 2026, little changed year-over-year from $5.4 million in Q2 2025, and little changed quarter-over-quarter from $5.4 million in Q1 2026.
Analysis
Skinvisible (SKVI) Non-Current Debt (2011 - 2026) Analysis & Trends
Skinvisible has disclosed Non-Current Debt across 16 years of filings, most recently posting $5.4 million for Q2 2026.
- In Q2 2026, Non-Current Debt changed 0.0% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $5.4 million (changed 0.0% YoY), while the FY2025 annual figure was $5.4 million, changed 0.0% from the prior year.
- Non-Current Debt came in at $5.4 million for Q2 2026 at Skinvisible, roughly flat from $5.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $5.4 million in Q2 2023 to a low of $433600.0 in Q1 2022.
- Average Non-Current Debt over 5 years is $4.4 million, with a median of $5.4 million recorded in 2023.
- Year-over-year, Non-Current Debt dropped 21.45% in 2022 and soared 1139.02% in 2023.
- Over 5 years, Non-Current Debt stood at $3.0 million in 2022, then soared by 79.55% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025, then changed by 0.0% to $5.4 million in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $5.4 million in Q2 2026, $5.4 million in Q1 2026, and $5.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.06 Bn | 626.30 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 440.06 Bn | 433.49 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 364.19 Bn | 357.05 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 268.45 Bn | 260.76 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.40 Bn | 146.70 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Sanofi | 52.57 Bn | 45.19 Bn | 10.79 Bn | 17.02 Bn |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | - |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.15 Bn | 18.49 Bn | 683.80 Mn | - |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 5.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.37 Mn |
| Mar 31, 2026 | 5.37 Mn |
| Dec 31, 2025 | 5.37 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 5.37 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Sep 30, 2024 | 5.37 Mn |
| Jun 30, 2024 | 5.37 Mn |
| Mar 31, 2024 | 5.37 Mn |
| Dec 31, 2023 | 5.37 Mn |
| Sep 30, 2023 | 5.37 Mn |
| Jun 30, 2023 | 5.37 Mn |
| Mar 31, 2023 | 5.37 Mn |
| Dec 31, 2022 | 2.99 Mn |
| Sep 30, 2022 | 433,600.00 |
| Jun 30, 2022 | 433,600.00 |
| Mar 31, 2022 | 433,600.00 |
| Dec 31, 2021 | 433,600.00 |
| Sep 30, 2021 | 445,600.00 |